MS
IONS icon

Maven Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Maven Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,400
Closed -$383K – 135
2018
Q3 		$383K Buy
+7,400
New +$348K 0.14% 109
2017
Q1 		– Sell
-1,176
Closed -$57K – 56
2016
Q4 		$57K Buy
+1,176
New +$46.5K 0.05% 36

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Maven Securities's IONS Position: Q4 2018 in Review

Maven Securities sold out of Ionis Pharmaceuticals (IONS) in Q4 2018, closing a stake of 7,400 shares — an estimated $383K sold.

Maven Securities first reported a position in IONS in Q4 2016 and held it in 2 quarters. The position peaked at $383K in Q3 2018. 329 funds tracked by Wall St. Rank hold IONS as of Q4 2018.

  • Maven Securities reported no remaining Ionis Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Maven Securities sold 7,400 Ionis Pharmaceuticals shares in Q4 2018, an estimated $383K.
  • Maven Securities first reported a position in Ionis Pharmaceuticals in Q4 2016 and held it in 2 quarters.
  • Maven Securities's Ionis Pharmaceuticals position peaked at $383K in Q3 2018.
  • 329 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2018.

Based on Maven Securities's 13F filing for Q4 2018, filed 14 Feb 2019.